Three trials were published comparing reboxetine against other antidepressants in which reboxetine was just as good, and they were published, but three times as many patients' worth of data was collected which showed that reboxetine was worse than those other treatments, and those trials were not published.
レボキセチンと他の抗うつ剤を比較した— 3つの治験が公開され 同等の効果が 認められていますが その3倍もの患者数を調べ レボキセチンは 他の抗うつ剤よりも劣るとわかったのに その3倍もの患者数を調べ レボキセチンは 他の抗うつ剤よりも劣るとわかったのに これらの処置や治験については論文になりませんでした